Trials / Withdrawn
WithdrawnNCT02911480
Assessment of Pharmacokinetics and Bioavailability of Carbon-14 ([14C])-Labelled Oxytocin
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Oxytone Bioscience BV · Industry
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The current study is designed as a phase I multiple dose study to evaluate the pharmacokinetics and bioavailability of \[14C\]-labelled oxytocin in healthy women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxytocin |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2017-02-01
- Completion
- 2017-08-31
- First posted
- 2016-09-22
- Last updated
- 2018-04-06
Source: ClinicalTrials.gov record NCT02911480. Inclusion in this directory is not an endorsement.